Severe toxic hepatitis associated with amoxycillin and clavulanic acid

Basit Öğe Kaydı
dc.contributor.authorErsoz, G
dc.contributor.authorKarasu, Z
dc.contributor.authorYildiz, C
dc.contributor.authorAkarca, US
dc.contributor.authorYuce, G
dc.contributor.authorBatur, Y
dc.date.accessioned2019-10-27T18:20:12Z
dc.date.available2019-10-27T18:20:12Z
dc.date.issued2001
dc.departmentEge Üniversitesien_US
dc.description.abstractToxic hepatitis secondary to amoxycillin-clavulanic acid is an infrequent clinical picture. Most of the cases are reported to have a benign course. We report two cases of severe hepatic failure following amoxycillin-clavulanic acid use. One of the cases had cholestatic features primarily, and the other had hepatocellular injury prominently. The first case had also findings of trombotic trombositic purpura and had a fatal course.en_US
dc.identifier.doi10.1046/j.1365-2710.2001.00341.xen_US
dc.identifier.endpage229en_US
dc.identifier.issn0269-4727
dc.identifier.issue3en_US
dc.identifier.pmid11422607en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage225en_US
dc.identifier.urihttps://doi.org/10.1046/j.1365-2710.2001.00341.x
dc.identifier.urihttps://hdl.handle.net/11454/35769
dc.identifier.volume26en_US
dc.identifier.wosWOS:000169495900011en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBlackwell Science Ltden_US
dc.relation.ispartofJournal of Clinical Pharmacy and Therapeuticsen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectamoxycillinen_US
dc.subjectclavulanic aciden_US
dc.subjecttoxic hepatitisen_US
dc.titleSevere toxic hepatitis associated with amoxycillin and clavulanic aciden_US
dc.typeEditorialen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu